From drugs to gene editing and brain implants, modern biotechnology has the potential to make humans stronger, more intelligent and perhaps even live longer. These ideas have largely existed at the fringes of scientific research, however, championed by eccentric billionaires whose aims include evading death. But investment and interest in human enhancement is growing—and some of those billionaires have now reached the heart of political power in America. How can human enhancement research be brought into the mainstream, so that it could one day benefit everyone?

Host: Alok Jha, The Economist’s science and technology editor, with health editor Natasha Loder. Contributors: Aron D'Souza of the Enhanced Games; Charles Brenner of City of Hope National Medical Center; Arthur Caplan of New York University Grossman School of Medicine; and Bryan Johnson, a tech entrepreneur and self-declared “rejuvenation athlete”.

If you enjoyed this, listen to The Weekend Intelligence’s episode on human growth hormone. How far would you go in the pursuit of perfection? 

Transcripts of our podcasts are available via economist.com/podcasts.

Listen to what matters most, from global politics and business to science and technology—subscribe to Economist Podcasts+.

For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.